Bart Neyns

Bart Neyns

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 190 publications

The past, present, and future treatment of BRAFV600-mutant metastatic colorectal cancer: A comprehensive review.

The past, present, and future treatment of BRAFV600-mutant metastatic colorectal cancer: A comprehensive review.

Journal: Cancer

Published: May 06, 2026

Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.

Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.

Journal: Journal for immunotherapy of cancer

Published: March 31, 2026

Reinvigorating the Cancer-Immunity Cycle by Intratumoral Administration of Conventional Dendritic Cells in Melanoma and Other Solid Tumors: A Narrative Review.

Reinvigorating the Cancer-Immunity Cycle by Intratumoral Administration of Conventional Dendritic Cells in Melanoma and Other Solid Tumors: A Narrative Review.

Journal: Vaccines

Published: March 30, 2026

Baseline vs. on-treatment heart failure with preserved ejection fraction (HFpEF) in a real world cardio-oncology clinic: observational analysis of cancer therapy-related cardiovascular toxicity incidence and cancer treatment implications.

Baseline vs. on-treatment heart failure with preserved ejection fraction (HFpEF) in a real world cardio-oncology clinic: observational analysis of cancer therapy-related cardiovascular toxicity incidence and cancer treatment implications.

Journal: Frontiers in cardiovascular medicine

Published: February 24, 2026

The Effectiveness of a Multidisciplinary Integrative Survivorship Program for Cancer-Related Cognitive Impairment: A Prospective Cohort Study.

The Effectiveness of a Multidisciplinary Integrative Survivorship Program for Cancer-Related Cognitive Impairment: A Prospective Cohort Study.

Journal: Cancers

Published: January 23, 2026

Efficacy and safety of regorafenib in patients with advanced pretreated melanoma: results of the RegoMel phase II clinical trial.

Efficacy and safety of regorafenib in patients with advanced pretreated melanoma: results of the RegoMel phase II clinical trial.

Journal: ESMO open

Published: January 09, 2026

Corrigendum to "Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028": [ESMO Open 10 (2025) 104295].

Corrigendum to "Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028": [ESMO Open 10 (2025) 104295].

Journal: ESMO open

Published: January 03, 2026

Immune Cell Infiltration in Primary and Recurrent Glioblastoma, IDH-Wild Type: Validation of an Immunohistochemistry-Based Scoring System for Research and Clinical Practice.

Immune Cell Infiltration in Primary and Recurrent Glioblastoma, IDH-Wild Type: Validation of an Immunohistochemistry-Based Scoring System for Research and Clinical Practice.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: November 11, 2025

Prognostic Value of O-(2-18F-Fluoroethyl)-l-Tyrosine PET for Patients with Recurrent Glioblastoma.

Prognostic Value of O-(2-18F-Fluoroethyl)-l-Tyrosine PET for Patients with Recurrent Glioblastoma.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: August 01, 2025

Extent of resection and its association with overall survival in newly diagnosed IDH wildtype glioblastoma treated with concomitant radiochemotherapy: a systematic review and meta-analysis.

Extent of resection and its association with overall survival in newly diagnosed IDH wildtype glioblastoma treated with concomitant radiochemotherapy: a systematic review and meta-analysis.

Journal: Brain & spine

Published: May 03, 2025

Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study.

Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 08, 2025

Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer.

Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer.

Journal: Nature communications

Published: February 28, 2025

Showing 1-12 of 190

Last Updated: 09/26/2026